Strong Q4; Gearing Up for U.S. Launch and Continued EU Ramp

Canaccord reiterates “buy” rating and remains bullish on the long-term growth prospects for HeartWare in a global LVAD market.

2011 02-25 HTWR – Strong Q4 – Buy – JMills